Neurology Central

ALKS 5461 receives refusal-to-file for depression: industry news round-up

In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more below about our selection of the highlights this week.
Our pick of the headlines include:
  • ALKS 5461 receives refusual-to-file for depression
  • Positive results reported for third study of cariprazine in bipolar I depression
  • Fast Track Designation granted for apomorphine in Parkinson’s disease
    Restricted Content / Members Only

    You cannot view this content because It is available to members only. Please or Register to view this area.